500 ARSENAL STREET, WATERTOWN, MA
Other Events
Stockholders Approve Amendment to 2019 Equity Incentive Plan
Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
Annual Report to Security Holders
Reports Financial Results for its Fiscal Fourth Quarter and Year -Ended September 30, 2025
News, Underwriting Agreement, Legal Opinion
Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
Investor Presentation
Q1
FY 2024
Q3
Q2
FY 2023
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence